Astrazeneca Pharma India Ltd. (ASTRAZEN): Astrazeneca Pharma India Share Price Hits Fresh 52-Week Low
- August 31, 2026
- Posted by: Harsh Piplani
- Category: News
Astrazeneca Pharma India Share Price was under pressure in today’s trade, with ASTRAZEN closing at Rs 7,017, down Rs 89.25 or 1.26% from the previous close of Rs 7,106.25. The move marked a fresh 52-week low at the same Rs 7,017 level, while market capitalisation stood at Rs 17,765.63 crore. The day opened at Rs 7,050, touched Rs 7,063, and then matched the session low at Rs 7,017. The supplied data confirms the price event, but it does not establish a company-specific catalyst. For readers tracking Astrazeneca Pharma India Share Price Today, the key takeaway is the new yearly low alongside a modest turnover of Rs 0.02 crore. Univest is therefore flagging the stock as a fresh one-year low event for closer factual tracking rather than interpretation beyond the numbers.
In ASTRAZEN Stock News, the event matters because a fresh 52-week low often draws attention to how the current share price compares with its recent range. Here, the stock finished exactly at the low of the day and the 52-week trough, which keeps Astrazeneca Pharma India Share Price in the spotlight for market participants following Astrazeneca Pharma India Share Price Live, Astrazeneca Pharma India Share Price Update and Astrazeneca Pharma India Stock News. The article below separates the day’s move from longer-term financial context so that Univest readers can see what is verified today and what is supported by the company’s disclosed metrics.
Astrazeneca Pharma India Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 7,017 |
| Previous Close | Rs 7,106.25 |
| Today's Move | Rs -89.25 (-1.26%) |
| Open | Rs 7,050 |
| High | Rs 7,063 |
| Low | Rs 7,017 |
| Turnover | Rs 0.02 crore |
| Market Capitalisation | Rs 17,765.63 crore |
Astrazeneca Pharma India Ltd. (ASTRAZEN) traded at Rs 7,017. versus the previous close of Rs 7,106.25, a fall of 1.26%. The stock opened at Rs 7,050, reached Rs 7,063, touched Rs 7,017.
Astrazeneca Pharma India Share Price Today reflected a narrow intraday range and a close at the session low. The stock opened at Rs 7,050, moved to a high of Rs 7,063, and then settled at Rs 7,017, which was also the day low and the fresh 52-week low. That leaves the day’s decline at Rs 89.25, or 1.26%, versus the previous close of Rs 7,106.25. Turnover came in at Rs 0.02 crore, while market capitalisation remained Rs 17,765.63 crore. Because the close matched the yearly low, this Astrazeneca Pharma India Share Price event stands out as a clear price milestone in today’s Stock Market Today and Share Market Today session. For investors following Astrazeneca Pharma India Share News or Astrazeneca Pharma India Latest News, the verified data shows the stock closed below the prior day’s level and at its one-year trough.
The key factual comparison is simple: the current price is lower than the previous close and equal to the fresh 52-week low. That places Astrazeneca Pharma India Share Price among the day’s Stocks in News and stocks at 52 week low, but the data alone does not assign a reason. Univest therefore treats this as a price event first, followed by fundamental and sector context rather than unsupported explanation.
Astrazeneca Pharma India Ltd. (ASTRAZEN) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 17,765.63 crore |
| P/E Ratio | 104.74x |
| P/B Ratio | 19.65x |
| ROE | 23.02% |
| ROCE | 31.24% |
| EPS | Rs 67.85 |
| Book Value Per Share | Rs 361.68 |
| Dividend Yield | 0.51% |
Astrazeneca Pharma India Ltd. (ASTRAZEN) fundamental metrics show P/E 104.74x, P/B 19.65x, ROE 23.02%, ROCE 31.24%. These figures provide context only and are not a buy or sell signal.
Astrazeneca Pharma India Ltd. has a market capitalisation of Rs 17765.63 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 104.74x, P/B at 19.65x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 23.02% and ROCE of 31.24%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 67.85, book value per share of Rs 361.68, dividend yield of 0.51%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.12x, median ROE of 11.78%, median ROCE of 13.59%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 104.74x |
| Benchmark Median P/E | 31.12x |
| Benchmark Average P/E | 47.77x |
| Benchmark P/E Range | 3.7x to 672.45x |
| Company P/B Ratio | 19.65x |
| Benchmark Median P/B | 2.87x |
| Company ROE | 23.02% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 31.24% |
| Benchmark Median ROCE | 13.59% |
| Company Market Capitalisation | Rs 17,765.63 crore |
| Benchmark Median Market Cap | Rs 630.79 crore |
Astrazeneca Pharma India Ltd. (ASTRAZEN) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Astrazeneca Pharma India Ltd. (ASTRAZEN) has a P/E ratio of 104.74x, which is above the benchmark median of 31.12x, a difference of +236.57%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Astrazeneca Pharma India Ltd. (ASTRAZEN) has a ROE of 23.02%, which is above the benchmark median of 11.78%, a difference of +95.42%. Astrazeneca Pharma India Ltd. (ASTRAZEN) has a ROCE of 31.24%, which is above the benchmark median of 13.59%, a difference of +129.87%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Shilpa Medicare Ltd. | SHILPAMED | 17,685.49 | 59.48 | 6.58 | 9.82 | 11.43 |
| Eris Lifesciences Ltd. | ERIS | 18,252.81 | 28.35 | 4.51 | 13.81 | 13.59 |
| Suven Pharmaceuticals Ltd. | COHANCE | 17,241.75 | 162.31 | 4.48 | 4.02 | 6.12 |
| Glenmark Life Sciences Ltd. | ALIVUS | 16,589.49 | 27.51 | 4.76 | 18.41 | 24.61 |
| Caplin Point Laboratories Ltd. | CAPLIPOINT | 19,125.3 | 28.74 | 5.08 | 21.72 | 26.22 |
Astrazeneca Pharma India Ltd. (ASTRAZEN) has a P/E ratio of 104.74x compared with the displayed peer median of 28.74x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 23.02% compares with a peer median of 13.81% across the companies shown in the table. ROCE stood at 31.24% versus the displayed peer median of 13.59%, providing a capital-efficiency comparison. Astrazeneca Pharma India Ltd. (ASTRAZEN) has a market capitalisation of Rs 17,765.63 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Astrazeneca Pharma India
- Astrazeneca Pharma India Share Price closed at Rs 7,017, which is also the fresh 52-week low and the day low.
- The stock fell Rs 89.25, or 1.26%, versus the previous close of Rs 7,106.25.
- Market capitalisation stood at Rs 17,765.63 crore, with turnover of Rs 0.02 crore.
- P/E was 104.74 and P/B was 19.65, both above the same-industry medians supplied in the data.
- ROE of 23.02% and ROCE of 31.24% were both above the sector benchmark medians in the dataset.
About Astrazeneca Pharma India
Astrazeneca Pharma India Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied financial data shows revenue progression across the last reported quarters, with net profit and revenue figures available for recent periods from Jun-25 through Jun-26. The company’s balance-sheet assets also increased across 2022, 2023 and 2024 in the supplied dataset. For readers following Astrazeneca Pharma India Company News or Astrazeneca Pharma India Latest News, the company profile is best read alongside the verified financial ratios and market-cap data rather than in isolation. Univest uses this factual company context to keep Astrazeneca Pharma India Share Price reporting grounded in the available numbers.
Track Astrazeneca Pharma India Share Price on Univest
Use Astrazeneca Pharma India Ltd. (ASTRAZEN) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
Readers can track Astrazeneca Pharma India Share Price on Univest for live share price updates, market capitalisation, P/E ratio, P/B ratio, ROE, ROCE, EPS, book value, dividend yield, shareholding pattern, 52-week levels and market insights. Univest brings the price event, sector context and financial ratios together in one place so that ASTRAZEN can be followed through a single research flow. For investors monitoring Astrazeneca Pharma India Share Price Today, Univest also helps connect company financials, peer comparison and market update data in a readable format.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Astrazeneca Pharma India Share Price hit a fresh 52-week low?
Ans. The verified data shows Astrazeneca Pharma India Share Price closed at Rs 7,017, which matched the fresh 52-week low. The dataset confirms the price event, but it does not establish a company-specific catalyst.
What is Astrazeneca Pharma India Share Price today?
Ans. Astrazeneca Pharma India Share Price today is Rs 7,017. It declined Rs 89.25, or 1.26%, from the previous close of Rs 7,106.25 and finished at the session low. The stock moved -1.26% during the session.
What is the market capitalisation of Astrazeneca Pharma India?
Ans. Astrazeneca Pharma India has a market capitalisation of Rs 17,765.63 crore. In the same-industry benchmark, the average market cap is Rs 14,022.09 crore and the median is Rs 630.79 crore.
How does Astrazeneca Pharma India Share Price compare with sector valuation?
Ans. Astrazeneca Pharma India Share Price carries a P/E of 104.74 and a P/B of 19.65. Both are above the same-industry median values of 31.12 and 2.87 in the supplied benchmark.
What do ROE and ROCE show for Astrazeneca Pharma India?
Ans. ROE is 23.02% and ROCE is 31.24%. Both figures are above the industry medians supplied in the dataset, which are 11.78% for ROE and 13.59% for ROCE. ROE stands at 23.02%.
What are Astrazeneca Pharma India EPS and book value?
Ans. EPS is Rs 67.85 and book value is Rs 361.68. EPS reflects earnings per share, while book value shows the accounting net worth behind each share in the company’s latest supplied data.
What is the dividend yield for Astrazeneca Pharma India Share Price?
Ans. The dividend yield is 0.51%. That figure is part of the supplied fundamentals and should be read as historical current data linked to the share price, not as a future payout guarantee.
How does Astrazeneca Pharma India compare with listed peers?
Ans. Against peers such as Eris Lifesciences, Glenmark Life Sciences and Caplin Point Laboratories, Astrazeneca Pharma India shows a higher valuation multiple and stronger ROE and ROCE in the supplied peer data.
What do recent company financials show for Astrazeneca Pharma India?
Ans. Recent net profit values include Rs 558.3 crore in Jun-25 and Rs 379.3 crore in Jun-26. Revenue rose to Rs 6,827.9 crore in Jun-26 from Rs 5,263.1 crore in Jun-25.
Where can investors track Astrazeneca Pharma India Share Price live?
Ans. Investors can track Astrazeneca Pharma India Share Price on Univest for live price updates, valuation ratios, shareholding pattern, 52-week levels and market insights, all in one research-friendly view. The stock moved -1.26% during the session.
